Navigation Links
Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting
Date:6/12/2008

Dr. Robert Leary Will Discuss Computational Methods for Model Evaluation;

Dr. Mike Dunlavey Will Present Simplified Programming Approaches of

Population Model User Interfaces

MOUNTAIN VIEW, Calif., June 12 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Pharsight software development experts will deliver two poster presentations at the Population Approach Group in Europe (PAGE) 17th Annual Meeting in Marseille, France from June 18-20, 2008. Robert Leary, Ph.D., fellow, Pharsight Research and Development Group, will present work on computational methods for model evaluation. Mike Dunlavey, Ph.D., fellow, Pharsight Research and Development Group, will present new approaches on simplified programming of population model user interfaces.

These poster sessions will provide a forum for pharmaceutical scientists from industry and academia to have scientific discussion and collaborative exchange on model-based approaches. Pharsight's two presentations are:

-- June 18: Simplified Programming of Population Model User Interfaces.

Dr. Dunlavey will present a differential execution algorithm that

allows a "painting" paradigm (called Dynamic Dialogs) as an alternative

to event-based programming. This programming paradigm simplifies

implementation of software products with complex graphical displays and

user interface requirements.

-- June 19: Nonparametric Analogs to POSTHOC Estimates for Exploratory

Data Analysis. Dr. Leary will present a nonparametric model evaluation

method to complement commonly used approaches for exploratory data

analysis of possible covariate relationships. This work builds on

applied research presented by industry colleagues at past PAGE

conferences and on Dr. Leary's earlier work in the area of nonlinear

mixed effects (NLME) analysis.

"The development of advanced computational tools and next generation programming languages are integral to the continued growth of model-based drug development," said Shawn O'Connor, president, CEO, and chairman of Pharsight. "We continue to develop technology to remain on the cutting edge of the industry and to create solutions that meet our customers' specific needs. Pharsight looks forward to presenting on specific elements of our vision for the future of model-based drug development, and is proud to again have such a wide presence at PAGE this year."

Additional information about PAGE can be found at http://www.page-meeting.org.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.

Registered Trademarks and Trademarks

Pharsight is a registered trademark of Pharsight Corporation. All other brand or product names mentioned in this document are trademarks or registered trademarks of their respective companies or organizations.


'/>"/>
SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting
2. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
3. Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop
4. Pharsight Strengthens Senior Management Team
5. Pharsight Announces Fiscal Fourth Quarter 2008 and Year End Earnings Release Date and Conference Call
6. Pharsight Signs New Diabetes Meta-Database Customer
7. Pharsight to Present at eClinical Forum
8. Pharsight to Host Webinar on Hepatitis C Virus (HCV) and HIV Drug-Disease Modeling
9. FDA and Pharsight Continue to Collaborate Under CRADA
10. Pharsight to Present at DIA Cardiac Safety Conference on December 4, 2007
11. Pharsight Achieves $7.3 Million in Quarterly Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: